Meningococcal Meningitis: Unprecedented Incidence of Serogroup X--Related Cases in 2006 in Niger
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In Niger, epidemic meningococcal meningitis is primarily caused by Neisseria meningitidis (Nm) serogroup A. However, since 2002, Nm serogroup W135 has been considered to be a major threat that has not yet been realized, and an unprecedented incidence of Nm serogroup X (NmX) meningitis was observed in 2006. METHODS: Meningitis surveillance in Niger is performed on the basis of reporting of clinically suspected cases. Cerebrospinal fluid specimens are sent to the reference laboratory in Niamey, Niger. Culture, latex agglutination, and polymerase chain reaction are used whenever appropriate. Since 2004, after the addition of a polymerase chain reaction-based nonculture assay that was developed to genogroup isolates of NmX, polymerase chain reaction testing allows for the identification of Nm serogroup A, Nm serogroup B, Nm serogroup C, NmX, Nm serogroup Y, and Nm serogroup W135. RESULTS: From January to June 2006, a total of 4185 cases of meningitis were reported, and 2905 cerebrospinal fluid specimens were laboratory tested. NmX meningitis represented 51% of 1139 confirmed cases of meningococcal meningitis, but in southwestern Niger, it represented 90%. In the agglomeration of Niamey, the reported cumulative incidence of meningitis was 73 cases per 100,000 population and the cumulative incidence of confirmed NmX meningitis was 27.5 cases per 100,000 population (74.6 cases per 100,000 population in children aged 5-9 years). NmX isolates had the same phenotype (X : NT : P1.5), and all belonged to the same sequence type (ST-181) as the NmX isolates that were circulating in Niamey in the 1990s. Nm serogroup W135 represented only 2.1% of identified meningococci. CONCLUSIONS: This is, to our knowledge, the first report of such a high incidence of NmX meningitis, although an unusually high incidence of NmX meningitis was also observed in the 1990s in Niamey. The increasing incidence of NmX meningitis is worrisome, because no vaccine has been developed against this serogroup. Countries in the African meningitis belt must prepare to face this potential new challenge.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A high incidence of serogroup X disease was recently reported for Niger, representing 51% of 1,139 confirmed cases of meningococcal meningitis in 2006 (36).”
From Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis (2010) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maiden, M. C. J., Bygraves, J. A., Feil, E., Morelli, G., Russell, J. E., Urwin, R., Zhang, Q., Zhou, J., Zurth, K., Caugant, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3140 · Cited by 3,833 · cited 1×
“A relevant selection of Nm isolates that had been collected during the meningitis epidemic season were sent to the World Health Organization’s Collaborating Centre for Reference and Research on Meningococci (Le Pharo, Marseilles, France) for serogroup confirmation, serotyping, and further determination, including mult…”
MethodBulletin of the World Health Organization
C., N. H. (1955) · The British Journal of Sociology · doi:10.2307/587237 · Cited by 3,601
mlstdbNet – distributed multi-locus sequence typing (MLST) databases
Jolley, K. A., Chan, M.-S., & Maiden, M. C. (2004) · BMC Bioinformatics · doi:10.1186/1471-2105-5-86 · Cited by 501 · cited 1×
“This publication made use of the Neisseria Multi Locus Sequence Typing website [26] developed by Keith Jolley and Man-Suen Chan and sited at the University of Oxford [29].”
MethodPCR for capsular typing of Haemophilus influenzae
Falla, T. J., Crook, D. W., Brophy, L. N., Maskell, D., Kroll, J. S., & Moxon, E. R. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.10.2382-2386.1994 · Cited by 413
Meningococcal meningitis in Africa
Greenwood, B. (1999) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(99)90106-2 · Cited by 358
Cerebrospinal meningitis in Africa.
Lapeyssonnie, L. (1963) · Europe PMC (PubMed Central) · Cited by 321
Taha, M.-K. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.2.855-857.2000 · Cited by 260 · cited 2×
“For genogrouping of Nm-positive specimens, a second PCR is performed to amplify the siaD gene for Nm serotypes B, C, Y, and W135, and the open reading frame 2 of the mynB gene for NmA [16].”
MethodSelf-citationEpidemiology of bacterial meningitis in Niamey, Niger, 1981-96.
Campagne, G., Schuchat, A., Djibo, S., Ousseini, A., Cissé, L., & Chippaux, J. (1999) · Europe PMC (PubMed Central) · Cited by 182
Self-citationGarcía, P., García, J., García, E., & López, R. (1986) · Gene · doi:10.1016/0378-1119(86)90215-5 · Cited by 168
Chatelet, I. P. D., Traore, Y., Gessner, B. D., Antignac, A., Naccro, B., Njanpop-Lafourcade, B.-M., Ouedraogo, M. S., Tiendrebeogo, S. R., Varon, E., & Taha, M. K. (2005) · Clinical Infectious Diseases · doi:10.1086/426436 · Cited by 158 · cited 6×
“In 2002, the first epidemic ever identified in Africa as being caused by Nm serogroup W135 occurred in Burkina Faso [9] [10], and the risk of a rapid spread of the epidemic within the meningitis belt was considered to be high.”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 10
- Koumare B, Bougoudogo F, Cisse M, Doumbia T, Keita MM. Bacte- riological aspects of purulent meningitis in Bamako district: a propos of 1541 bacterial strains collected from 1979 to 1991 [in French]. Bull Soc Pathol Exot 1993; 86:136-40.
- 1993, Bulletin de la Soci t de pathologie exotique (1990), 86, 136
- Gagneux SP, Hodgson A, Smith TA, et al. Prospective study of a se- rogroup X Neisseria meningitidis outbreak in northern Ghana. J Infect Dis 2002; 185:618-26.
- Parent du Chatelet I, Traore Y, Gessner BD, et al. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain re- action testing. Clin Infect Dis 2005; 40:17-25.
- World Health Organization. Meningococcal disease, serogroup W135, Burkina Faso: preliminary report, 2002. Wkly Epidemiol Rec 2002; 77: 152-5.
- World Health Organization (WHO). Enhanced surveillance of epi- demic meningococcal meningitis in Africa: a three-year experience. Wkly Epidemiol Rec 2005; 80:313-20.
- 2002, Weekly epidemiological record / Health Section of the Secretariat of the League of Nations, 77, 152
- 2005, Weekly epidemiological record / Health Section of the Secretariat of the League of Nations, 80, 313
- Multi Disease Surveillance Centre (MDSC). Epidemiological situation of week 22 to 26, 2006. MDSC Meningitis Weekly Bulletin. Ouaga- dougou: World Health Organization-Regional Office for Africa, 2006.
- Traore Y, Njanpop-Lafourcade BM, Adjogble KL, et al. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005. Clin Infect Dis 2006; 43:817-22.
Cited by
Items 201–269 of 269
Mandiarote, A., Gutiérrez, N., Valmaseda, T., Sosa, R., Ontivero-Pino, I., Talavera, A. F., Álvarez-Tito, M., Aranguren, Y., Ochoa, R. F., & García, L. G. (2012) · Vaccimonitor/VacciMonitor · Cited by 4
Erondu, N. A. (2016) · LSHTM Research Online (London School of Hygiene and Tropical Medicine) · doi:10.17037/pubs.02603680 · Cited by 4
“Additionally, serogroups X, Y, and W emerge sporadically and have caused several African outbreaks in the last decade (56-60).”
BackgroundAnalysis of novel meningococcal vaccine formulations
Zughaier, S. M. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1305528 · Cited by 4
“As expected, other meningococcal disease-causing serogroups emerged in Africa like serogroup W and X which is a considerable concern and advocates for a wider vaccine serogroups coverage.(16,17) In addition to persistent low carriage of meningococcal serogroup A, other serogroups like Y and X are causing meningococcal…”
BackgroundKy-Ba, A., Mahamoudou, S., Trancho, J. D., Christiasen, P. A., Ouédraogo, A., Tamboura, M., Kambiré, D., Ouattara, K., Kienou, M., Sanou, I., et al. (2015) · African Journal of Clinical and Experimental Microbiology · doi:10.4314/ajcem.v17i1.2 · Cited by 3
Taha, M. (2012) · EMC-Maladies infectieuses/Encyclopédie médico-chirurgicale. Maladies infectieuses · doi:10.1016/s1166-8598(12)58119-6 · Cited by 3
Self-citationPeletiri, I. C., Ikeh, E., Ayanbimpe, G. M., & Nna, E. (2021) · African Journal of Clinical and Experimental Microbiology · doi:10.4314/ajcem.v22i3.8 · Cited by 3
“The sacB gene is targeted for serogroup A and the xcbA gene, which most likely encodes the capsule polymerase, is targeted for serogroup X (6,7).”
BackgroundHuang, R., Huang, D., Sun, C., Zhou, J., Jia, N., Xiao, F., Huang, X., Li, S., & Wang, Y. (2024) · ACS Omega · doi:10.1021/acsomega.4c07249 · Cited by 3
Godjedo, T. P. M., Agbankpe, A. J., Paraïso, M. N., Dougnon, T. V., Hidjo, M., Baba‐Moussa, L., & Bankole, H. S. (2020) · Advances in Public Health · doi:10.1155/2020/1932940 · Cited by 3
“To detect epidemics, routine surveillance of suspected cases of acute bacterial meningitis is carried out in Benin and in all the other countries of the African meningitis belt according to WHO recommendations [13], although the recommendation to divide large districts of more than 100,000 inhabitants into subdistrict…”
Methodvan Putten, J. P. M., & Tønjum, T. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-04579-7.00168-4 · Cited by 3
Impact of « MenAfrivac» on Meningococcal Meningitis from 2010 to 2022 in Burkina Faso
(2025) · ACTA SCIENTIFIC MICROBIOLOGY · doi:10.31080/asmi.2025.08.1510 · Cited by 2
Emergence ofNeisseria meningitidisW-135 in the context of other rare serogroups
da Silva, L. J., DeTora, L. M., Malerczyk, C., & Memish, Z. A. (2012) · Clinical Investigation · doi:10.4155/cli.11.165 · Cited by 2
Despite successful vaccines Neisseria meningitidis strikes again
Jacobsson, S. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30273-0 · Cited by 2
Effects of periodic aerosol emission on the transmission dynamics of Neisseria Meningitis A
Signing, F., Tsanou, B., Lubuma, J. M.-S., & Bowong, S. (2022) · Mathematics and Computers in Simulation · doi:10.1016/j.matcom.2022.06.005 · Cited by 2
Findlow, J., Kriz, P., & Pace, D. (2012) · Cited by 2
Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007
Norheim, G., Mueller, J. E., Njanpop‐Lafourcade, B., Delrieu, I., Findlow, H., Borrow, R., Xie, O., Nagaputra, J. C., Ramasamy, R., Dold, C., et al. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.01.031 · Cited by 2
“meningitidis (MenX) isolates were first documented in the meningitis belt in 1970, but have recently emerged as a cause of more substantial localized disease outbreaks in subSaharan Africa in the last ten years, in both West and East Africa [4,5].”
BackgroundBacterial meningitis in adults: clinical characteristics, risk factors and adjunctive treatment
Brouwer, M. C. (2010) · UvA-DARE (University of Amsterdam) · Cited by 3
Impact of Changing Epidemiology on Vaccination Strategies in Africa
Taha, M., & Deghmane, A. (2010) · Future Microbiology · doi:10.2217/fmb.10.57 · Cited by 2
Self-citationKristiansen, P. A. (2013) · NORA - Norwegian Open Research Archives · Cited by 2
Charles‐Orszag, A. (2017) · theses.fr (ABES) · doi:10.70675/6e6f3a21zbe80z4a49z8b14z3cef1cbad444 · Cited by 2
Topaz, N., Kristiansen, P. A., Schmink, S. E., Congo-Ouédraogo, M., Kambiré, D., Mbaeyi, S. A., Paye, M. F., Mahamoudou, S., Sangaré, L., Ouédraogo, R., et al. (2020) · Microbial Genomics · doi:10.1099/mgen.0.000486 · Cited by 1
“Neisseria meningitidis serogroup A has historically been responsible for most epidemics in the region [2], but other serogroups such as X [3], W [2, 4] and more recently C [5, 6] have all caused major outbreaks.”
BackgroundNeisseria meningitidis Meningitis in Burkina Faso: Review of the Literature
Savadogo, M., & Ouédraogo, P. D. N. (2022) · Asian Journal of Research in Infectious Diseases · doi:10.9734/ajrid/2022/v11i4231 · Cited by 1
Pinto, T., Kocaata, Z., Medina, A., Sampietri, I. C., Bernardino, G., Zawieja, J., Gil-Rojas, Y., Tytuła, A., Graña, M. G., & Kuylen, E. (2026) · Infectious Diseases and Therapy · doi:10.1007/s40121-026-01322-7 · Cited by 1
“Twelve serogroups of N. meningitidis have been identified, and six of them (MenA, MenB, MenC, MenW, MenX, and MenY) are responsible for the majority of IMD cases worldwide [1, 2].”
Molecular Typing of Neisseria meningitidis
Taha, M., & Deghmane, A. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-185-1_12 · Cited by 1
Self-citationSequelae following an epidemic of meningococcal meningitis in Niger in 2022
Idrissa, A., Atti, S., Wasaulua, R., Kazadi, S., Sani, O., Tassiou, E. I., Guindo, O., Tonamou, G., Ciglenečki, I., & Coldiron, M. E. (2025) · PLoS ONE · doi:10.1371/journal.pone.0323223 · Cited by 1
Neisseria meningitis serogroup X outbreak in Burkina Faso, 2009-2010
Yaro, S., Drabo, A., Ouangraoua, S., Kirakoya‐Samadoulougou, F., Mueller, J. E., Sanou, O., Tall, H., Jaillard, P., Njanpop‐Lafourcade, B., Macq, J., et al. (2012) · Open Journal of Internal Medicine · doi:10.4236/ojim.2012.22010 · Cited by 1
“Niger is moreover a West African country which had described the greatest number of meningitis serogroup X cases, with the first cases isolated in 1982 [23].”
BackgroundInfluentialKy-Ba, A., Tranchot‐Diallo, J., Sanou, I., Christiansen, P. D., Ouedraogo, A., Ouattara, K., Kienou, M., Tamboura, M., Kambiré, D., Ouedraogo-Traoré, R., et al. (2015) · African Journal of Clinical and Experimental Microbiology · doi:10.4314/ajcem.v17i1.1 · Cited by 1
Alamro, M. S. (2015) · Figshare · Cited by 1
Characterisation of genomic islands in Neisseria meningitidis
Catenazzi, M. C. E. (2013) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 1
Leimkugel, J. (2007) · edoc (University of Basel) · doi:10.5451/unibas-004208281 · Cited by 1
The role of fructose-1,6-bisphosphate aldolase (FBA) in the pathogenesis of Neisseria meningitidis
Shams, F. M. (2016) · Nottingham ePrints (University of Nottingham) · Cited by 1
The role of phase-variable expression of meningococcal surface proteins during carriage and disease
Bidmos, F. A. (2013) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Vaccines to Prevent Bacterial Meningitis in Children
Domachowske, J. B. (2012) · InTech eBooks · doi:10.5772/29703
Trascriptome analysis and functional genomics of Neisseria meningitidis in human blood
Tordello, E. D. (2012) · PubMed · doi:10.6092/unibo/amsdottorato/4819
“The introduction of new virulent clones into a population can change the epidemiology and the clinical spectrum of meningococcal disease and the recent emergence of serogroup X meningococci in Niger [17] highlights the need for continued surveillance for new clonal complexes.”
BackgroundVacuna antimeningocócica conjugada tetravalente
Roman, Y. M., & Campins, M. (2011) · Anales de Pediatría Continuada · doi:10.1016/s1696-2818(11)70018-x
The Role of Lactoferrin Binding Protein B in Gram-Negative Pathogens
Morgenthau, A. (2013) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/28329
Brehony, C. (2010) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-jb1xgxpdd
Fagnocchi, L. (2013) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/5655
“Out of these, six are responsible for more than 90% of meningococcal disease worldwide: A, B, C, X, Y and W [2, 22-24].”
BackgroundUniversal Epidemiology of Insidious Meningococcal Syndrome
Valsa, G., & Shkurti, E. (2015) · European Journal of Interdisciplinary Studies · doi:10.26417/ejis.v1i1.p25-36
Hung, M.-C. (2012) · ePrints Soton (University of Southampton)
Wang, B. (2014) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Spinsanti, M. (2016) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/7659
The population structure of bacterial pathogens
Watkins, E. (2015) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-vyxk8vvbg
Bartley, S. N. (2012) · UWA Profiles and Research Repository (UWA)
Computational approaches to vaccine development for multi-strain pathogens
Walker, A. (2017) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-nrdwxko08
Improving Adolescent Health Through Immunisation: A Case Study - Invasive Meningococcal Disease
Wang, B. (2019) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Structure-function relationships of bacterial sialate O-acetyltransferases
Bergfeld, A. K. (2009) · Institutional Repository of Leibniz Universität Hannover (Leibniz Universität Hannover) · doi:10.15488/7173
Principato, S., Bini, L., & Brunelli, B. (2021) · Use Siena air (University of Siena) · doi:10.25434/silvia-principato_phd2021
Tønjum, T., Brandtzaeg, P., & Henriques‐Normark, B. (2013) · Springer eBooks · doi:10.1007/978-3-642-30144-5_106
Baudner, B. C., & Rappuoli, R. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8412-6_12
Rappuoli, R. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733181118.793546588
Meningococcal Syndrome in Albanian Children
(2016) · International Journal of Science and Research (IJSR) · doi:10.21275/v5i2.nov161197
Braimah, J. O., & Correa, F. M. (2024) · Nigerian Journal of Medicine · doi:10.4103/njm.njm_65_24
Patni, S., Verma, R., Desarda, M., Naikwade, S., Deorukhakar, H., Dhere, R. M., & Mallya, A. D. (2025) · Journal of Immunological Methods · doi:10.1016/j.jim.2025.113895
Macêdo, L. E. N. (2022) · Arca - Repositório Institucional da Fiocruz
Investigating the interaction between Neisseria meningitidis and human FGFR1
Alsuwat, M. A. (2022) · Nottingham ePrints (University of Nottingham)
The Trend of Meningitis in Guilan Province, Northern Iran During 2011-2022: An Ecological Study
Ghalandari, M., Madadizadeh, F., Zahraei, S. M., Lotfi, M. H., & Dehghani, A. (2025) · Epidemiology and Health System Journal · doi:10.34172/ehsj.26425
Métabolisme du carbone et virulence chez Neisseria meningitidis
Derkaoui, M. (2015) · theses.fr (ABES) · doi:10.70675/4fc106e4zae29z4b74z88b8z1f421f0bfd3e
Role of the innate immune response in vascular damage caused by Neisseria meningitidis infection
Rojas, V. M. (2018) · theses.fr (ABES) · doi:10.70675/aa3bf510zf25ez4d6azb517z474dd4b94494
Sevestre, J. (2018) · theses.fr (ABES) · doi:10.70675/269fada9zf58cz4ad8zb125z8b1aa204c23e
Minimal structural glyco-epitope for antibody recognition
Robakiewicz, S. (2020) · theses.fr (ABES) · doi:10.70675/72508b78zf24bz46f6zaf89zb1d4e7428c9d
Recent advances in the development of a vaccine to target meningococcal serogroup X
Townsend‐Payne, K., Louth, J. C., Borrow, R., & Clark, S. A. (2026) · Expert Review of Vaccines · doi:10.1080/14760584.2026.2707148
Brobby, G. W. (2012)
The role of glutamine synthetase in the pathogenesis of Neisseia meningitidis
Turner, I. (2020) · Nottingham ePrints (University of Nottingham)
Fu, D., Li, K., Shi, X., Zhang, F., 郑佳, Yu, J., Xue, Z., Gao, S., Lu, C., Sun, G., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1943863
Vacca, I. (2014) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/6490
Metadata
- Authors
- Boisier, P., Nicolas, P., Djibo, S., Taha, M.-K., Jeanne, I., Mainassara, H. B., Tenebray, B., Kairo, K. K., Giorgini, D., & Chanteau, S.
- Affiliations
- Centre de Recherche Médicale et Sanitaire (NE)
- World Health Organization (CH)
- Institut Pasteur (FR)
- Ministère de la Santé Publique (NE)
- Corresponding author
- Boisier, P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-03-01
- Volume
- 44
- Issue
- 5
- Pages
- 657-663
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2159099211
- Cited by
- 237
- References
- 26
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 5 · 2020: 7 · 2019: 8 · 2018: 12 · 2017: 12 · 2016: 15 · 2015: 14 · 2014: 21 · 2013: 23 · 2012: 34
- FWCI
- 16.38
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Own your potential (DEAKIN) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- World Health Organization
- Wellcome Trust
- University of Oxford
- European Commission
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Keywords
- meningococcal meningitis, serogroup W135, epidemic meningitis, meningitis incidence, Niger, Niamey, serogroup replacement, children aged 5-9 years
- MeSH terms
- Disease Outbreaks, Humans, Meningitis, Meningococcal, Neisseria meningitidis, Niger, Serotyping, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.